Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...] …
Category: Pharma Industry
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novo Nordisk will issue its fifth round of refunds this year on prices charged to 340B providers. The latest are [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The fifth and final fiscal year 2023 manufacturer audit by federal officials recently concluded with no adverse findings. Meanwhile, the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two Republican Senators on an influential committee suggested during a hearing on Tuesday that 340B discounts could contribute to certain [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal auditors determined terminations from the 340B program were required for either covered entity sites or contract pharmacies of four [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...] …